Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
Anal Biochem. 2013 May 15;436(2):78-83. doi: 10.1016/j.ab.2013.01.018. Epub 2013 Jan 29.
SIRT6 is a histone deacetylase that has been proposed as a potential therapeutic target for metabolic disorders and the prevention of age-associated diseases. Thus the identification of compounds that modulate SIRT6 activity could be of great therapeutic importance. We have previously reported on the identification of quercetin and vitexin as SIRT6 inhibitors, using SIRT6-coated magnetic beads. In this study, we have immobilized SIRT6 onto the surface of an open tubular capillary and characterized the quercetin binding site using frontal displacement chromatography. Structurally related flavonoids were tested for their activity on SIRT6, including apigenin, naringenin, luteolin, and kaempferol. In addition to obtaining their binding activity using frontal affinity chromatographic techniques, we also ranked the compounds based on their ability to displace quercetin. The data suggest that a single displacement curve is representative of the enzymatic activity of the tested ligand. In addition, using the inhibition data obtained in this study, we developed a preliminary pharmacophore model that confirmed the experimental data.
SIRT6 是一种组蛋白去乙酰化酶,被认为是治疗代谢紊乱和预防与年龄相关疾病的潜在靶点。因此,鉴定能够调节 SIRT6 活性的化合物可能具有重要的治疗意义。我们之前曾报道过使用 SIRT6 涂覆的磁珠鉴定槲皮素和牡荆素为 SIRT6 抑制剂。在这项研究中,我们将 SIRT6 固定在开放式管状毛细管的表面上,并使用前沿置换色谱法对其进行表征。用结构相关的类黄酮测试它们对 SIRT6 的活性,包括芹菜素、柚皮素、木犀草素和山柰酚。除了使用前沿亲和色谱技术获得它们的结合活性外,我们还根据它们置换槲皮素的能力对化合物进行了排名。数据表明,单个置换曲线代表了测试配体的酶活性。此外,使用本研究中获得的抑制数据,我们开发了一个初步的药效团模型,该模型证实了实验数据。